Medpace Holdings, Inc. Investigated by the Portnoy Law Firm

LOS ANGELES, April 01, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Medpace Holdings, Inc., (“Medpace" or the "Company") (NASDAQ:MEDP) investors that the firm has initiated an investigation into possible securities fraud, and may file a class action on behalf of investors.

Investors are encouraged to contact attorney Lesley F. Portnoy, by phone 310-692-8883 or email: lesley@portnoylaw.com, to discuss their legal rights, or join the case via https://portnoylaw.com/medpace-holdings-inc. The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors’ options for pursuing claims to recover their losses.

Medpace’s stock price fell $79.88, or 18.3%, to close at $357.30 per share on July 23, 2024, thereby injuring investors. This sharp decline followed the July 22, 2024, post-market release of the Company’s second quarter 2024 financial results, which significantly underperformed relative to expectations. During a subsequent earnings call on July 23, management revealed that “cancellations were disproportionately high in the month of June.” The Company identified several drivers for this trend, including “impaired sponsor liquidity,” “reprioritization,” and a specific instance where a sponsor was acquired by a large pharmaceutical firm that opted to “move the work to an existing preferred provider,” effectively terminating the Medpace contract.

The Portnoy Law Firm represents investors in pursuing claims caused by corporate wrongdoing. The Firm’s founding partner has recovered over $5.5 billion for aggrieved investors. Attorney advertising. Prior results do not guarantee similar outcomes.

Lesley F. Portnoy, Esq.
Admitted CA, NY and TX Bar
lesley@portnoylaw.com
310-692-8883
www.portnoylaw.com

Attorney Advertising

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.